Description
Tirz is studied for its dual activation of GIP and GLP-1 receptors, supporting improved glucose control and insulin signaling. In research models, this dual incretin activity has demonstrated enhanced glycemic regulation compared to single-pathway approaches.
This product is sold as a pure research compound and is not intended for human consumption or use as a dietary supplement, drug, or treatment. It is provided solely for laboratory research purposes and must not be used for diagnostic or therapeutic purposes, in food, cosmetics, or any medical applications.
The statements on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition. All products are for research and development use only.
Products sold strictly for scientific study in controlled lab settings. Buyer assumes all responsibility for compliance.
Reviews
There are no reviews yet.